Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer.
about
Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasionCollagen binding specificity of the discoidin domain receptors: binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signalingExpression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinomaInduction of neurite outgrowth through contactin and Nr-CAM by extracellular regions of glial receptor tyrosine phosphatase betaDiscoidin Domain Receptors: Potential Actors and Targets in CancerCloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptorThe discoidin domain receptor tyrosine kinase DDR1 in arterial wound repairDDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cellsThe collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism.Discoidin domain receptor 1 functions in axon extension of cerebellar granule neuronsDiscoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland developmentInhibition of collagen fibrillogenesis by cells expressing soluble extracellular domains of DDR1 and DDR2DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin.Semi-automatic classification of skeletal morphology in genetically altered mice using flat-panel volume computed tomographyLoss of Kindlin-1 causes skin atrophy and lethal neonatal intestinal epithelial dysfunction.Discoidin domain receptors in disease.Discoidin domain receptor functions in physiological and pathological conditions.Identification of novel driver mutations of the discoidin domain receptor 2 (DDR2) gene in squamous cell lung cancer of Chinese patients.Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator ZtaIntegrative DNA methylation and gene expression analysis identifies discoidin domain receptor 1 association with idiopathic nonobstructive azoospermiaA discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration.Discoidin domain receptor 1: isoform expression and potential functions in cirrhotic human liver.p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop.Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer.DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation.Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements.Collagen recognition and transmembrane signalling by discoidin domain receptorsDiscoidin domain receptor tyrosine kinases: new players in cancer progressionDDR2 polymorphisms and mRNA expression in lung cancers of Japanese patients.Motogenic and morphogenic activity of epithelial receptor tyrosine kinases.Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.Shedding of discoidin domain receptor 1 by membrane-type matrix metalloproteinases.Discoidin domain receptor-1 and periostin: new players in chronic kidney diseaseRegulation of collagen fibrillogenesis by cell-surface expression of kinase dead DDR2Transcriptome analysis reveals an unexpected role of a collagen tyrosine kinase receptor gene, Ddr2, as a regulator of ovarian function.Synthesis and biological applications of collagen-model triple-helical peptides.Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth.DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study.Myocardial fibroblast-matrix interactions and potential therapeutic targets
P2860
Q21245706-09720BF3-30AD-4982-95FB-E9A669DF2EE5Q24305308-5891FEDE-F25B-42BB-8C58-E7164619ADA7Q24604831-3EBD8C66-8175-4DF6-A69C-C9C84702065EQ24653663-5D118100-864E-46B6-ADDA-7642224FB3FEQ24683911-9285AB3F-B842-4013-BE42-332714BF9B54Q26751157-55C44FCD-3C09-41BA-B190-78850D54803BQ28115617-007C5603-8FF7-4F59-8E13-7EA39BD24AAAQ28360490-C773E564-2C63-41DB-A536-9AF511060AFEQ28363500-037D6111-0E03-455B-BDEC-85AA4234177BQ28365928-37577A29-FAF5-4F0C-BB4A-E2B6BC4DF24AQ28571037-A7C4DD37-DAAC-4B37-83B9-CF3B88EB25ADQ28589694-63E78632-5A40-45E0-8BEB-A03889677405Q28590800-8E7C0B1C-F49F-4B4A-8F2E-E8B49E3C242BQ30499285-50465B77-8E6A-4BA1-BB1D-26F11B5A1E73Q33292017-E2F37889-8048-4676-AA31-B3B70BD874CBQ33389852-1133B5E9-FC0D-414F-847D-EE2E06DEE912Q33605357-4DD115DB-59F0-4519-8E0F-F9A6C6BFE77CQ33611605-6A7C43CD-083B-45A6-BB2C-4D84952C2BCAQ33690276-2CC5A44A-A18A-4854-A490-2B7B8E03EF96Q33809585-A6748AA2-4CD1-4D12-B6CC-53C153E855F2Q34287814-CCA47A21-4D6D-4970-A289-A1DB3BF806DFQ34661632-CD497AF5-546F-4635-9851-E01CEE2DC1A9Q34760613-9C8B8B05-D904-42A7-A270-F449CBA9A8FEQ34794097-091DA969-8734-4DC6-8F27-8FCB5BF4FA40Q34874796-1400048E-5522-4D17-A875-1770458A0BF1Q34978948-FA4634E0-3DA0-4901-AF11-8C43D5281279Q35088118-AD91DF3D-1FE3-4C1E-AB2D-739E9E3B8D50Q35094710-364F2F7B-6623-4A0E-A90A-C8650AA1DF5CQ35957518-8569F792-6DD8-46DA-B842-DFD641DBA3E5Q36099324-AEC77A44-DBAC-45E9-8F9F-4B098DFE8C52Q36236949-E88C9E4C-0042-4B87-9726-2A1E1EF3A8C5Q36265839-C69BC7D9-DD70-4B14-8F4C-77387BD6B4CFQ36796884-CE05B130-9984-457D-9940-D6B0CBAB28EEQ36801573-600E444A-190F-4079-81FE-1375CF03F8BAQ37179463-88F679FE-EF17-4EC2-87F2-471C74AA3DEFQ37394765-FE9F2E5C-47A5-429B-850D-3CECAC668ABDQ37632930-50B3A645-9943-4140-8C09-79AA54DB64E2Q37674735-FF1D9E75-B342-4068-B6AA-0F638E0EE3ADQ37694728-0131B181-116A-430D-BE05-4660BC17F062Q37734270-E268AC10-F295-4B20-B970-1EE4695A57F4
P2860
Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer.
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Distinct structural characteri ...... ry expression in human cancer.
@ast
Distinct structural characteri ...... ry expression in human cancer.
@en
type
label
Distinct structural characteri ...... ry expression in human cancer.
@ast
Distinct structural characteri ...... ry expression in human cancer.
@en
prefLabel
Distinct structural characteri ...... ry expression in human cancer.
@ast
Distinct structural characteri ...... ry expression in human cancer.
@en
P2093
P1433
P1476
Distinct structural characteri ...... ry expression in human cancer.
@en
P2093
P304
P407
P577
1995-02-01T00:00:00Z